EEAK Consulting

Ten years in public markets.

Before that, regulated industry, government and management consulting. The firm is led by Katharyn Field: chief executive of three listed companies, chairman of two, director of six more, across seven industries. Stanford and Columbia Business School. Everything below is drawn from the companies’ own filings and can be checked.

A chief executive’s office at first light: an empty leather chair turned toward the window, a squared stack of paper on the desk.

Operating roles

  • Interim Chief Executive Officer, President and Chief Financial Officer, BioRestorative Therapies (Nasdaq: BRTX)

    July to August 2026, and a director to August 2026. Departure at the executive's own request, with a transition consulting arrangement thereafter.

  • Chief Executive Officer, iSpecimen (Nasdaq: ISPC)

    Appointed November 2025. President from February 2025. Chairman and independent director before that.

  • Chief Executive Officer and Chairman, Halo Collective

    2022 to 2025. President 2020 to 2022. Chief Strategy Officer 2019 to 2020. Publicly listed in Canada.

  • Executive Vice President, Corporate Development, MariMed (OTC: MRMD)

    2018 to 2019.

Board roles

  • Director, Nuwellis (Nasdaq: NUWE)

    January to March 2026.

  • Director, T-REX Acquisition Corp (OTC: TRXA)

    January to May 2026.

  • Director, LogProstyle (Nasdaq: LGPS)

    Since September 2024.

  • Director and audit committee member, Virpax Pharmaceuticals (Nasdaq: VRPX)

    July 2024 to April 2025, including a period as principal executive officer.

  • Executive Director, Akanda Corp (Nasdaq: AKAN)

    Since June 2022.

  • Director, Aerwins Technologies (Nasdaq: AWIN)

Before public markets

  • Bain & Company, consultant
  • The Brookings Institution, operations
  • The White House, Office of Public Liaison
  • A licensed Florida medical treatment center: procurement, build-out and sale, from 2014

Education

  • MBA, Strategy and Economics, Columbia Business School
  • BA with honors, Public Policy, Stanford University

Industries

Biospecimens and diagnostics. Cell therapy and biotechnology. Pharmaceuticals. Medical devices. Regulated cannabis. Advanced air mobility. Real estate and hospitality.

If you have read this far, the next step is a conversation.

Confidential, and with the person who would do the work. Expect a reply within one business day.

Start a conversation